Provider
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Medicaid
Quantity Limit
Program effective Date: Jun 01, 2024
Search Results
Displaying 1261 - 1270 of 3661 results
Provider
Atypical Antipsychotics - Commercial
Step Therapy, Quantity Limit
Program effective Date: Jan 01, 2025
Provider
QP33-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2024
Program effective Date: Apr 10, 2024
Provider
QP31-24 Rare Disease Benefit Mandate
Program effective Date: Apr 10, 2024
Provider
QP37-24 Update for New-to-Market Medical Drugs: atidarsagene autotemcel, crovalimab, and fidanacogene eleparvovec
Program effective Date: May 08, 2024
Provider
P16-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Program effective Date: Mar 01, 2024
Provider
P15-24 New Medical, Medical Drug and Behavioral Health Policy Management Updates, Effective May 6, 2024
Program effective Date: Mar 01, 2024
Provider
P14-24 Medicare Part B Step Therapy Program Expansion to Include Rystiggo, and Vyvgart Hytrulo
Program effective Date: Mar 01, 2024
Provider
P13-24 Medical Record Requirements Reminder
Program effective Date: Mar 01, 2024